LOCUS       NP_776656                418 aa                     MAM 01-FEB-2014
DEFINITION  beta-2 adrenergic receptor [Bos taurus].
ACCESSION   NP_776656
VERSION     NP_776656.1  GI:41386782
KEYWORDS    RefSeq.
SOURCE      Bos taurus (cattle)
  ORGANISM  Bos taurus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Laurasiatheria; Cetartiodactyla; Ruminantia;
            Pecora; Bovidae; Bovinae; Bos.
REFERENCE   1  (residues 1 to 418)
  AUTHORS   Rekawiecki R, Nowocin A and Kotwica J.
  TITLE     Relationship between concentrations of progesterone, oxytocin,
            noradrenaline, gene expression and protein level for their receptors
            in corpus luteum during estrous cycle in the cow
  JOURNAL   Prostaglandins Other Lipid Mediat. 92 (1-4), 13-18 (2010)
   PUBMED   20149890
  REMARK    GeneRIF: relationship between luteal concentrations of oxytocin
            (OT), noradrenaline (NA), progesterone (P4), oxytocin receptors
            (OT-R) and beta(2)-adrenoreceptors (beta(2)-R) gene expression and
            their protein level throughout the estrous cycle
REFERENCE   2  (residues 1 to 418)
  AUTHORS   Zimin AV, Delcher AL, Florea L, Kelley DR, Schatz MC, Puiu D,
            Hanrahan F, Pertea G, Van Tassell CP, Sonstegard TS, Marcais G,
            Roberts M, Subramanian P, Yorke JA and Salzberg SL.
  TITLE     A whole-genome assembly of the domestic cow, Bos taurus
  JOURNAL   Genome Biol. 10 (4), R42 (2009)
   PUBMED   19393038
REFERENCE   3  (residues 1 to 418)
  AUTHORS   Carron J, Morel C, Hammon HM and Blum JW.
  TITLE     Ontogenetic development of mRNA levels and binding sites of hepatic
            beta-adrenergic receptors in cattle
  JOURNAL   Domest. Anim. Endocrinol. 28 (3), 320-330 (2005)
   PUBMED   15760672
  REMARK    GeneRIF: beta 1,2 and 3-adrenergic receptors in cattle were
            positively associated with hepatic activities of gluconeogenetic
            enzymes and with plasma glucose levels, suggesting functional
            importance
REFERENCE   4  (residues 1 to 418)
  AUTHORS   Inderwies T, Pfaffl MW, Meyer HH, Blum JW and Bruckmaier RM.
  TITLE     Detection and quantification of mRNA expression of alpha- and
            beta-adrenergic receptor subtypes in the mammary gland of dairy cows
  JOURNAL   Domest. Anim. Endocrinol. 24 (2), 123-135 (2003)
   PUBMED   12586313
  REMARK    GeneRIF: of the beta-adrenergic receptors, adrenergic
            beta(2)-receptor type was most highly expressed in the mammary gland
            of dairy cows followed by beta(1) and beta(3)
REFERENCE   5  (residues 1 to 418)
  AUTHORS   Schimpf RJ, Schmutz SM and Buchanan FC.
  TITLE     Genetic mapping of the ADRB2 gene on cattle chromosome 7
  JOURNAL   Anim. Genet. 32 (6), 390 (2001)
   PUBMED   11736812
REFERENCE   6  (residues 1 to 418)
  AUTHORS   Einspanier R, Gabler C, Kettler A and Kloas W.
  TITLE     Characterization and localization of beta2-adrenergic receptors in
            the bovine oviduct: indication for progesterone-mediated expression
  JOURNAL   Endocrinology 140 (6), 2679-2684 (1999)
   PUBMED   10342858
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from Z86037.1.
            ##Evidence-Data-START##
            Transcript exon combination :: Z86037.1 [ECO:0000332]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..418
                     /db_xref="taxon:9913"
                     /breed="Simmental"
                     /organism="Bos taurus"
                     /chromosome="7"
                     /map="7"
     Protein         1..418
                     /note="adrenergic, beta-2, receptor, surface; adrenergic
                     receptor beta 2; beta-2 adrenoceptor; beta-2
                     adrenoreceptor"
                     /product="beta-2 adrenergic receptor"
                     /calculated_mol_wt="47005"
     Site            35..58
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          48..340
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          57..326
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            72..95
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            107..129
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            151..174
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          193..207
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            197..220
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            275..298
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          286..293
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Site            306..329
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          312..316
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist and antagonist binding (By
                     similarity)"
     Region          415..418
                     /note="propagated from UniProtKB/Swiss-Prot (Q28044.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="PDZ-binding"
     CDS             1..418
                     /coded_by="NM_174231.1:224..1480"
                     /gene="ADRB2"
                     /db_xref="BGD:BT12038"
                     /db_xref="GeneID:281605"
ORIGIN
        1 mgqpgnrsvf llapnashap dqnvtlerde awvvgmgilm slivlaivfg nvlvitaiak
       61 ferlqtvtny fitslacadl vmglavvpfg achilmkmwt fgnfwcefwt sidvlcvtas
      121 ietlcviavd rylaitspfk yqclltknka rvvilmvwiv sgltsflpiq mhwyrashke
      181 aincyaketc cdfftnqpya iassivsfyl plvvmvfvys rvfqvakrql qkidksegrf
      241 haqnvsqveq dgrsglgqrr tskfylkehk alktlgiimg tftlcwlpff ivnivhvikd
      301 nlirkeiyil lnwlgyinsa fnpliycrsp dfriafqell clrrsslkay gngcssnsnd
      361 rtdytgeqsg yhlgeekdse llcedppgte nfvnqqgtvp sdsidsqgrn cstndsll
//
